WITTE OWEN N. 4
4 · Allogene Therapeutics, Inc. · Filed Aug 15, 2022
Insider Transaction Report
Form 4
WITTE OWEN N.
Director
Transactions
- Sale
Common Stock
2022-08-11$16.50/sh−10,000$165,000→ 223,271 total - Sale
Common Stock
2022-08-12$17.25/sh−5,000$86,250→ 218,271 total